{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:40:31Z","timestamp":1791308431413,"version":"4.3.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T00:00:00Z","timestamp":1675728000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Vet Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Osteoarthritis (OA) pain is the number one cause of chronic pain in dogs. Multimodal treatment, including combining safe and effective nutritional interventions with non-steroidal anti-inflammatory drugs (NSAIDs), is currently considered one of the most appropriate choices for managing OA pain. Palmitoyl-glucosamine is a feed material belonging to the ALIAmide family, whose parent molecule is the prohomeostatic lipid amide N-palmitoyl-ethanolamine. Curcumin is a promising plant antioxidant. The present study aimed at investigating whether 18-week dietary integration with palmitoyl-glucosamine co-micronized with curcumin was able to maintain pain relief in dogs with OA-associated chronic pain receiving meloxicam (1.5\u00a0mg\/ml oral suspension) on a tapering regimen (progressive 25% decrease of the original 0.1\u00a0mg\/kg\/day dose, on a biweekly basis) during the first 8\u00a0weeks of treatment. Pain was assessed both by the owners and veterinary surgeons, with the first using both subjective evaluation and validated metrology instruments\u2014i.e., Helsinki Chronic Pain Index (HCPI) and Canine Brief Pain Inventory (CBPI)\u2014while the second rating the severity of lameness and pain on palpation on two previously used 5-point scales.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of fifty-eight dogs with OA chronic pain entered the uncontrolled study. Pain on HCPI was considered severe at baseline (range 18\u201339). Based on owner\u2019s assessment, 90% of dogs who responded to meloxicam at the full-dose regimen could reduce meloxicam up to 25% of the original dose without experiencing pain worsening. Moreover, 75% of dogs was assessed as having no pain increase ten weeks after meloxicam withdrawal. A statistically significant decrease of pain severity as scored by HCPI (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001) was observed two and ten weeks after meloxicam withdrawal compared to study entry (17.0\u2009\u00b1\u20091.05 and 15.1\u2009\u00b1\u20091.02, respectively, <jats:italic>vs<\/jats:italic> 29.0\u2009\u00b1\u20090.74; mean\u2009\u00b1\u2009SEM). After meloxicam withdrawal, no statistically significant change in the CBPI scores was recorded. Pain on palpation and lameness significantly changed to less severe distributions along the study period (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.0001).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>The findings appear to suggest that dietary integration with palmitoyl-glucosamine co-micronized with curcumin was able to maintain meloxicam-induced pain relief in dogs with severe OA chronic pain.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12917-023-03594-4","type":"journal-article","created":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T04:43:45Z","timestamp":1675745025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Palmitoyl-glucosamine co-micronized with curcumin for maintenance of meloxicam-induced pain relief in dogs with osteoarthritis pain"],"prefix":"10.1186","volume":"19","author":[{"given":"Giorgia","family":"della Rocca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Schievano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Di Salvo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Beatrice","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Federica","family":"della Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,2,7]]},"reference":[{"key":"3594_CR1","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1208\/s12248-013-9467-5","volume":"15","author":"M Sharkey","year":"2013","unstructured":"Sharkey M. The challenges of assessing osteoarthritis and postoperative pain in dogs. AAPS J. 2013;15:598\u2013607.","journal-title":"AAPS J"},{"key":"3594_CR2","first-page":"45","volume":"29","author":"A Vezzoni","year":"2015","unstructured":"Vezzoni A, Miolo A. Il dolore ortopedico del cane: indagine tra i medici veterinari italiani. Veterinaria. 2015;29:45\u201353.","journal-title":"Veterinaria"},{"key":"3594_CR3","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1111\/papr.12551","volume":"17","author":"M Fusco","year":"2017","unstructured":"Fusco M, Skaper SD, Coaccioli S, Varrassi G, Paladini A. Degenerative Joint Diseases and Neuroinflammation. Pain Pract. 2017;17:522\u201332.","journal-title":"Pain Pract"},{"key":"3594_CR4","doi-asserted-by":"publisher","first-page":"1759720X2199506","DOI":"10.1177\/1759720X21995067","volume":"13","author":"F Puntillo","year":"2021","unstructured":"Puntillo F, Giglio M, Paladini A, Perchiazzi G, Viswanath O, Urits I, et al. Pathophysiology of musculoskeletal pain: a narrative review. Ther Adv Musculoskelet Dis. 2021;13:1759720X21995067.","journal-title":"Ther Adv Musculoskelet Dis."},{"key":"3594_CR5","doi-asserted-by":"publisher","first-page":"952","DOI":"10.3390\/ani11040952","volume":"11","author":"G della Rocca","year":"2021","unstructured":"della Rocca G, Gamba D. Chronic Pain in Dogs and Cats: Is There Place for Dietary Intervention with Micro-Palmitoylethanolamide? Animals (Basel). 2021;11:952.","journal-title":"Animals (Basel)."},{"key":"3594_CR6","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3389\/fvets.2016.00012","volume":"3","author":"SA Moore","year":"2016","unstructured":"Moore SA. Managing Neuropathic Pain in Dogs. Front Vet Sci. 2016;3:12.","journal-title":"Front Vet Sci"},{"key":"3594_CR7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1136\/vr.102823","volume":"176","author":"A-M Barcelos","year":"2015","unstructured":"Barcelos A-M, Mills DS, Zulch H. Clinical indicators of occult musculoskeletal pain in aggressive dogs. Vet Rec. 2015;176:465.","journal-title":"Vet Rec"},{"key":"3594_CR8","doi-asserted-by":"publisher","first-page":"2808","DOI":"10.3390\/ani12202808","volume":"12","author":"JC Alves","year":"2022","unstructured":"Alves JC, Santos A, Jorge P, Lavrador C, Carreira LM. Evaluation of Four Clinical Metrology Instruments for the Assessment of Osteoarthritis in Dogs. Animals (Basel). 2022;12:2808.","journal-title":"Animals (Basel)"},{"issue":"Suppl 107","key":"3594_CR9","first-page":"53","volume":"35","author":"BD Cimino","year":"2017","unstructured":"Cimino BD. What can we learn from osteoarthritis pain in companion animals? Clin Exp Rheumatol. 2017;35(Suppl 107):53\u20138.","journal-title":"Clin Exp Rheumatol"},{"key":"3594_CR10","doi-asserted-by":"publisher","first-page":"830098","DOI":"10.3389\/fvets.2022.830098","volume":"9","author":"C Mosley","year":"2022","unstructured":"Mosley C, Edwards T, Romano L, Truchetti G, Dunbar L, Schiller T, et al. Proposed Canadian Consensus Guidelines on Osteoarthritis Treatment Based on OA-COAST Stages 1\u20134. Front Vet Sci. 2022;9:830098.","journal-title":"Front Vet Sci"},{"key":"3594_CR11","first-page":"E4","volume":"34","author":"S Perea","year":"2012","unstructured":"Perea S. Nutritional management of osteoarthritis. Compend Contin Educ Vet. 2012;34:E4.","journal-title":"Compend Contin Educ Vet"},{"key":"3594_CR12","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1136\/vr.152.11.323","volume":"152","author":"M Moreau","year":"2003","unstructured":"Moreau M, Dupuis J, Bonneau NH, Desnoyers M. Clinical evaluation of a nutraceutical, carprofen and meloxicam for the treatment of dogs with osteoarthritis. Vet Rec. 2003;152:323\u20139.","journal-title":"Vet Rec"},{"key":"3594_CR13","first-page":"296","volume":"41","author":"PA Doig","year":"2000","unstructured":"Doig PA, Purbrick KA, Hare JE, McKeown DB. Clinical efficacy and tolerance of meloxicam in dogs with chronic osteoarthritis. Can Vet J. 2000;41:296\u2013300.","journal-title":"Can Vet J"},{"key":"3594_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.2460\/javma.2004.225.1056","volume":"225","author":"KD Peterson","year":"2004","unstructured":"Peterson KD, Keefe TJ. Effects of meloxicam on severity of lameness and other clinical signs of osteoarthritis in dogs. J Am Vet Med Assoc. 2004;225:1056\u201360.","journal-title":"J Am Vet Med Assoc"},{"key":"3594_CR15","doi-asserted-by":"publisher","first-page":"514","DOI":"10.2460\/javma.230.4.514","volume":"230","author":"CL Aragon","year":"2007","unstructured":"Aragon CL, Hofmeister EH, Budsberg SC. Systematic review of clinical trials of treatments for osteoarthritis in dogs. J Am Vet Med Assoc. 2007;230:514\u201321.","journal-title":"J Am Vet Med Assoc"},{"key":"3594_CR16","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1136\/vr.102435","volume":"175","author":"MB Walton","year":"2014","unstructured":"Walton MB, Cowderoy EC, Wustefeld-Janssens B, Lascelles BDX, Innes JF. Mavacoxib and meloxicam for canine osteoarthritis: a randomised clinical comparator trial. Vet Rec. 2014;175:280.","journal-title":"Vet Rec"},{"key":"3594_CR17","doi-asserted-by":"publisher","first-page":"14192","DOI":"10.1038\/s41598-019-50623-0","volume":"9","author":"ME Gruen","year":"2019","unstructured":"Gruen ME, Samson DR, Lascelles BDX. Functional linear modeling of activity data shows analgesic-mediated improved sleep in dogs with spontaneous osteoarthritis pain. Sci Rep. 2019;9:14192.","journal-title":"Sci Rep"},{"key":"3594_CR18","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1136\/vr.c97","volume":"166","author":"JF Innes","year":"2010","unstructured":"Innes JF, Clayton J, Lascelles BDX. Review of the safety and efficacy of long-term NSAID use in the treatment of canine osteoarthritis. Vet Rec. 2010;166:226\u201330.","journal-title":"Vet Rec"},{"key":"3594_CR19","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1111\/j.1939-1676.2011.00825.x","volume":"25","author":"BGJ Wernham","year":"2011","unstructured":"Wernham BGJ, Trumpatori B, Hash J, Lipsett J, Davidson G, Wackerow P, et al. Dose reduction of meloxicam in dogs with osteoarthritis-associated pain and impaired mobility. J Vet Intern Med. 2011;25:1298\u2013305.","journal-title":"J Vet Intern Med"},{"key":"3594_CR20","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/978-3-030-04624-8_24","volume-title":"Nutraceuticals in Veterinary Medicine","author":"RC Gupta","year":"2019","unstructured":"Gupta RC, Doss RB, Lall R, Srivastava A, Sinha A. Nutraceuticals in Arthritis. In: Gupta RC, Srivastava A, Lall R, editors. Nutraceuticals in Veterinary Medicine. Cham: Springer International Publishing; 2019. p. 365\u201381."},{"key":"3594_CR21","doi-asserted-by":"publisher","first-page":"318","DOI":"10.3415\/VCOT-17-02-0020","volume":"30","author":"RM Scott","year":"2017","unstructured":"Scott RM, Evans R, Conzemius MG. Efficacy of an oral nutraceutical for the treatment of canine osteoarthritis. A double-blind, randomized, placebo-controlled prospective clinical trial. Vet Comp Orthop Traumatol. 2017;30:318\u201323.","journal-title":"Vet Comp Orthop Traumatol."},{"key":"3594_CR22","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1053\/j.tcam.2017.10.003","volume":"32","author":"JC Alves","year":"2017","unstructured":"Alves JC, Santos AM, Jorge PI. Effect of an Oral Joint Supplement When Compared to Carprofen in the Management of Hip Osteoarthritis in Working Dogs. Top Companion Anim Med. 2017;32:126\u20139.","journal-title":"Top Companion Anim Med"},{"key":"3594_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.plefa.2016.03.015","volume":"109","author":"SJ Mehler","year":"2016","unstructured":"Mehler SJ, May LR, King C, Harris WS, Shah Z. A prospective, randomized, double blind, placebo-controlled evaluation of the effects of eicosapentaenoic acid and docosahexaenoic acid on the clinical signs and erythrocyte membrane polyunsaturated fatty acid concentrations in dogs with osteoarthritis. Prostaglandins Leukot Essent Fatty Acids. 2016;109:1\u20137.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"3594_CR24","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1111\/j.1939-1676.2010.0572.x","volume":"24","author":"D Fritsch","year":"2010","unstructured":"Fritsch D, Allen TA, Dodd CE, Jewell DE, Sixby KA, Leventhal PS, et al. Dose-titration effects of fish oil in osteoarthritic dogs. J Vet Intern Med. 2010;24:1020\u20136.","journal-title":"J Vet Intern Med"},{"key":"3594_CR25","doi-asserted-by":"publisher","first-page":"E78","DOI":"10.3390\/vetsci7020078","volume":"7","author":"E Gugliandolo","year":"2020","unstructured":"Gugliandolo E, Peritore AF, Piras C, Cuzzocrea S, Crupi R. Palmitoylethanolamide and Related ALIAmides: Prohomeostatic Lipid Compounds for Animal Health and Wellbeing. Vet Sci. 2020;7:E78.","journal-title":"Vet Sci"},{"key":"3594_CR26","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1186\/s13075-019-2048-y","volume":"21","author":"M Cordaro","year":"2019","unstructured":"Cordaro M, Siracusa R, Impellizzeri D, D\u2019 Amico R, Peritore AF, Crupi R, et al. Safety and efficacy of a new micronized formulation of the ALIAmide palmitoylglucosamine in preclinical models of inflammation and osteoarthritis pain. Arthritis Res Ther. 2019;21:254.","journal-title":"Arthritis Res Ther."},{"key":"3594_CR27","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.3390\/ijms22031491","volume":"22","author":"M Iannotta","year":"2021","unstructured":"Iannotta M, Belardo C, Trotta MC, Iannotti FA, Vitale RM, Maisto R, et al. N-palmitoyl-D-glucosamine, a Natural Monosaccharide-Based Glycolipid, Inhibits TLR4 and Prevents LPS-Induced Inflammation and Neuropathic Pain in Mice. Int J Mol Sci. 2021;22:1491.","journal-title":"Int J Mol Sci"},{"key":"3594_CR28","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.vetimm.2012.04.001","volume":"147","author":"M Colitti","year":"2012","unstructured":"Colitti M, Gaspardo B, Della Pria A, Scaini C, Stefanon B. Transcriptome modification of white blood cells after dietary administration of curcumin and non-steroidal anti-inflammatory drug in osteoarthritic affected dogs. Vet Immunol Immunopathol. 2012;147:136\u201346.","journal-title":"Vet Immunol Immunopathol"},{"key":"3594_CR29","doi-asserted-by":"publisher","first-page":"e0252279","DOI":"10.1371\/journal.pone.0252279","volume":"16","author":"C Caterino","year":"2021","unstructured":"Caterino C, Aragosa F, Della Valle G, Costanza D, Lamagna F, Piscitelli A, et al. Clinical efficacy of Curcuvet and Boswellic acid combined with conventional nutraceutical product: An aid to canine osteoarthritis. PLoS ONE. 2021;16:e0252279.","journal-title":"PLoS ONE"},{"key":"3594_CR30","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12917-017-1317-8","volume":"13","author":"F Comblain","year":"2017","unstructured":"Comblain F, Barth\u00e9l\u00e9my N, Lef\u00e8bvre M, Schwartz C, Lesponne I, Serisier S, et al. A randomized, double-blind, prospective, placebo-controlled study of the efficacy of a diet supplemented with curcuminoids extract, hydrolyzed collagen and green tea extract in owner\u2019s dogs with osteoarthritis. BMC Vet Res. 2017;13:395.","journal-title":"BMC Vet Res"},{"key":"3594_CR31","doi-asserted-by":"publisher","first-page":"E1827","DOI":"10.3390\/ani10101827","volume":"10","author":"E Gugliandolo","year":"2020","unstructured":"Gugliandolo E, Peritore AF, Impellizzeri D, Cordaro M, Siracusa R, Fusco R, et al. Dietary Supplementation with Palmitoyl-Glucosamine Co-Micronized with Curcumin Relieves Osteoarthritis Pain and Benefits Joint Mobility. Animals (Basel). 2020;10:E1827.","journal-title":"Animals (Basel)"},{"key":"3594_CR32","first-page":"39","volume":"8","author":"RM Asperio","year":"2020","unstructured":"Asperio RM. Integrazione dietetica con PGA-Cur: indagine osservazionale su 181 cani con osteoartrite [Dietary supplementation with PGA-cur: a survey on 181 osteoarthritis dogs]. Summa. 2020;8:39\u201348.","journal-title":"Summa"},{"key":"3594_CR33","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2460\/javma.241.10.1314","volume":"241","author":"MG Conzemius","year":"2012","unstructured":"Conzemius MG, Evans RB. Caregiver placebo effect for dogs with lameness from osteoarthritis. J Am Vet Med Assoc. 2012;241:1314\u20139.","journal-title":"J Am Vet Med Assoc"},{"key":"3594_CR34","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1038\/s41598-021-82795-z","volume":"11","author":"JC Alves","year":"2021","unstructured":"Alves JC, Santos A, Jorge P, Lavrador C, Carreira LM. Intraarticular triamcinolone hexacetonide, stanozolol, Hylan G-F 20 and platelet concentrate in a naturally occurring canine osteoarthritis model. Sci Rep. 2021;11:3118.","journal-title":"Sci Rep"},{"key":"3594_CR35","doi-asserted-by":"publisher","first-page":"609889","DOI":"10.3389\/fvets.2020.609889","volume":"7","author":"JC Alves","year":"2020","unstructured":"Alves JC, Santos A, Jorge P, Lavrador C, Carreira LM. Intra-articular Injections With Either Triamcinolone Hexacetonide, Stanozolol, Hylan G-F 20, or a Platelet Concentrate Improve Clinical Signs in Police Working Dogs With Bilateral Hip Osteoarthritis. Front Vet Sci. 2020;7:609889.","journal-title":"Front Vet Sci"},{"key":"3594_CR36","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1186\/s12917-021-02913-x","volume":"17","author":"JC Alves","year":"2021","unstructured":"Alves JC, Santos A, Jorge P. Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis. BMC Vet Res. 2021;17:207.","journal-title":"BMC Vet Res"},{"key":"3594_CR37","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1093\/ecam\/nem136","volume":"6","author":"A Hielm-Bj\u00f6rkman","year":"2009","unstructured":"Hielm-Bj\u00f6rkman A, Tulamo R-M, Salonen H, Raekallio M. Evaluating Complementary Therapies for Canine Osteoarthritis Part I: Green-lipped Mussel (Perna canaliculus). Evid Based Complement Alternat Med. 2009;6:365\u201373.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3594_CR38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1093\/ecam\/nem143","volume":"6","author":"A Hielm-Bj\u00f6rkman","year":"2009","unstructured":"Hielm-Bj\u00f6rkman A, Tulamo R-M, Salonen H, Raekallio M. Evaluating complementary therapies for canine osteoarthritis\u2013Part II: a homeopathic combination preparation (Zeel). Evid Based Complement Alternat Med. 2009;6:465\u201371.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3594_CR39","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.tvjl.2014.01.020","volume":"200","author":"HM Heikkil\u00e4","year":"2014","unstructured":"Heikkil\u00e4 HM, Hielm-Bj\u00f6rkman AK, Morelius M, Larsen S, Honkavaara J, Innes JF, et al. Intra-articular botulinum toxin A for the treatment of osteoarthritic joint pain in dogs: a randomized, double-blinded, placebo-controlled clinical trial. Vet J. 2014;200:162\u20139.","journal-title":"Vet J"},{"key":"3594_CR40","doi-asserted-by":"publisher","first-page":"2076921","DOI":"10.1155\/2016\/2076921","volume":"2016","author":"GOL Carapeba","year":"2016","unstructured":"Carapeba GOL, Cavaleti P, Nic\u00e1cio GM, Brinholi RB, Giuffrida R, Cassu RN. Intra-Articular Hyaluronic Acid Compared to Traditional Conservative Treatment in Dogs with Osteoarthritis Associated with Hip Dysplasia. Evid Based Complement Alternat Med. 2016;2016:2076921.","journal-title":"Evid Based Complement Alternat Med"},{"key":"3594_CR41","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/1746-6148-8-157","volume":"8","author":"A Hielm-Bj\u00f6rkman","year":"2012","unstructured":"Hielm-Bj\u00f6rkman A, Roine J, Elo K, Lappalainen A, Junnila J, Laitinen-Vapaavuori O. An un-commissioned randomized, placebo-controlled double-blind study to test the effect of deep sea fish oil as a pain reliever for dogs suffering from canine OA. BMC Vet Res. 2012;8:157.","journal-title":"BMC Vet Res"},{"key":"3594_CR42","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41584-019-0202-1","volume":"15","author":"RL Meeson","year":"2019","unstructured":"Meeson RL, Todhunter RJ, Blunn G, Nuki G, Pitsillides AA. Spontaneous dog osteoarthritis - a One Medicine vision. Nat Rev Rheumatol. 2019;15:273\u201387.","journal-title":"Nat Rev Rheumatol"},{"key":"3594_CR43","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1111\/j.1467-2995.2011.00675.x","volume":"39","author":"B KuKanich","year":"2012","unstructured":"KuKanich B, Bidgood T, Knesl O. Clinical pharmacology of nonsteroidal anti-inflammatory drugs in dogs. Vet Anaesth Analg. 2012;39:69\u201390.","journal-title":"Vet Anaesth Analg"},{"key":"3594_CR44","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1939-1676.2007.0014.x","volume":"22","author":"BDX Lascelles","year":"2008","unstructured":"Lascelles BDX, Gaynor JS, Smith ES, Roe SC, Marcellin-Little DJ, Davidson G, et al. Amantadine in a multimodal analgesic regimen for alleviation of refractory osteoarthritis pain in dogs. J Vet Intern Med. 2008;22:53\u20139.","journal-title":"J Vet Intern Med"},{"key":"3594_CR45","doi-asserted-by":"publisher","first-page":"e58125","DOI":"10.1371\/journal.pone.0058125","volume":"8","author":"MB Walton","year":"2013","unstructured":"Walton MB, Cowderoy E, Lascelles D, Innes JF. Evaluation of construct and criterion validity for the \u201cLiverpool Osteoarthritis in Dogs\u201d (LOAD) clinical metrology instrument and comparison to two other instruments. PLoS ONE. 2013;8:e58125.","journal-title":"PLoS ONE"},{"key":"3594_CR46","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1016\/j.cvsm.2013.04.007","volume":"43","author":"B KuKanich","year":"2013","unstructured":"KuKanich B. Outpatient oral analgesics in dogs and cats beyond nonsteroidal antiinflammatory drugs: an evidence-based approach. Vet Clin North Am Small Anim Pract. 2013;43:1109\u201325.","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"3594_CR47","doi-asserted-by":"publisher","first-page":"ajvr22.03.0036","DOI":"10.2460\/ajvr.22.03.0036","volume":"83","author":"JC Alves","year":"2022","unstructured":"Alves JC, Santos A, Jorge P, Carreira LM. A randomized double-blinded controlled trial on the effects of photobiomodulation therapy in dogs with osteoarthritis. Am J Vet Res. 2022;83:ajvr22.03.0036.","journal-title":"Am J Vet Res."},{"key":"3594_CR48","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1111\/jvim.12127","volume":"27","author":"BP Monteiro-Steagall","year":"2013","unstructured":"Monteiro-Steagall BP, Steagall PVM, Lascelles BDX. Systematic review of nonsteroidal anti-inflammatory drug-induced adverse effects in dogs. J Vet Intern Med. 2013;27:1011\u20139.","journal-title":"J Vet Intern Med"},{"key":"3594_CR49","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1016\/j.fct.2011.05.001","volume":"49","author":"P Dadhaniya","year":"2011","unstructured":"Dadhaniya P, Patel C, Muchhara J, Bhadja N, Mathuria N, Vachhani K, et al. Safety assessment of a solid lipid curcumin particle preparation: acute and subchronic toxicity studies. Food Chem Toxicol. 2011;49:1834\u201342.","journal-title":"Food Chem Toxicol"},{"key":"3594_CR50","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/jvim.12004","volume":"27","author":"DC Brown","year":"2013","unstructured":"Brown DC, Boston RC, Farrar JT. Comparison of force plate gait analysis and owner assessment of pain using the Canine Brief Pain Inventory in dogs with osteoarthritis. J Vet Intern Med. 2013;27:22\u201330.","journal-title":"J Vet Intern Med"},{"key":"3594_CR51","doi-asserted-by":"publisher","first-page":"197","DOI":"10.5326\/JAAHA-MS-6239","volume":"51","author":"AL Lomas","year":"2015","unstructured":"Lomas AL, Grauer GF. The renal effects of NSAIDs in dogs. J Am Anim Hosp Assoc. 2015;51:197\u2013203.","journal-title":"J Am Anim Hosp Assoc"},{"key":"3594_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.prevetmed.2016.07.017","volume":"131","author":"Z Belshaw","year":"2016","unstructured":"Belshaw Z, Asher L, Dean RS. The attitudes of owners and veterinary professionals in the United Kingdom to the risk of adverse events associated with using non-steroidal anti-inflammatory drugs (NSAIDs) to treat dogs with osteoarthritis. Prev Vet Med. 2016;131:121\u20136.","journal-title":"Prev Vet Med"},{"key":"3594_CR53","unstructured":"Center for Veterinary Medicine. Veterinary Non-Steroidal Anti-Inflammatory Drugs (NSAIDs). FDA. 2021. https:\/\/www.fda.gov\/animal-veterinary\/product-safety-information\/veterinary-non-steroidal-anti-inflammatory-drugs-nsaids. Accessed 13 Jan 2022."},{"key":"3594_CR54","first-page":"237","volume":"6","author":"BDX Lascelles","year":"2005","unstructured":"Lascelles BDX, McFarland JM, Swann H. Guidelines for safe and effective use of NSAIDs in dogs. Vet Ther. 2005;6:237\u201351.","journal-title":"Vet Ther"},{"key":"3594_CR55","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2460\/ajvr.70.6.727","volume":"70","author":"AK Hielm-Bj\u00f6rkman","year":"2009","unstructured":"Hielm-Bj\u00f6rkman AK, Rita H, Tulamo R-M. Psychometric testing of the Helsinki chronic pain index by completion of a questionnaire in Finnish by owners of dogs with chronic signs of pain caused by osteoarthritis. Am J Vet Res. 2009;70:727\u201334.","journal-title":"Am J Vet Res"},{"key":"3594_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1186\/s12917-017-0990-y","volume":"13","author":"HM Heikkil\u00e4","year":"2017","unstructured":"Heikkil\u00e4 HM, Hielm-Bj\u00f6rkman AK, Innes JF, Laitinen-Vapaavuori OM. The effect of intra-articular botulinum toxin A on substance P, prostaglandin E2, and tumor necrosis factor alpha in the canine osteoarthritic joint. BMC Vet Res. 2017;13:74.","journal-title":"BMC Vet Res"},{"key":"3594_CR57","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.2460\/javma.2003.222.1552","volume":"222","author":"AK Hielm-Bj\u00f6rkman","year":"2003","unstructured":"Hielm-Bj\u00f6rkman AK, Kuusela E, Liman A, Markkola A, Saarto E, Huttunen P, et al. Evaluation of methods for assessment of pain associated with chronic osteoarthritis in dogs. J Am Vet Med Assoc. 2003;222:1552\u20138.","journal-title":"J Am Vet Med Assoc"},{"key":"3594_CR58","doi-asserted-by":"publisher","first-page":"631","DOI":"10.2460\/ajvr.68.6.631","volume":"68","author":"DC Brown","year":"2007","unstructured":"Brown DC, Boston RC, Coyne JC, Farrar JT. Development and psychometric testing of an instrument designed to measure chronic pain in dogs with osteoarthritis. Am J Vet Res. 2007;68:631\u20137.","journal-title":"Am J Vet Res"},{"key":"3594_CR59","doi-asserted-by":"publisher","first-page":"736458","DOI":"10.3389\/fvets.2021.736458","volume":"8","author":"G Della Rocca","year":"2021","unstructured":"Della Rocca G, Di Salvo A, Medori C, Della Valle MF, Cimino BD. Initial Psychometric Testing and Validation of the Italian Version of the Canine Brief Pain Inventory in Dogs With Pain Related to Osteoarthritis. Front Vet Sci. 2021;8:736458.","journal-title":"Front Vet Sci"},{"key":"3594_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fvets.2016.00081","volume":"3","author":"R Harman","year":"2016","unstructured":"Harman R, Carlson K, Gaynor J, Gustafson S, Dhupa S, Clement K, et al. A Prospective, Randomized, Masked, and Placebo-Controlled Efficacy Study of Intraarticular Allogeneic Adipose Stem Cells for the Treatment of Osteoarthritis in Dogs. Front Vet Sci. 2016;3:81.","journal-title":"Front Vet Sci"},{"key":"3594_CR61","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s12917-015-0413-x","volume":"11","author":"BDX Lascelles","year":"2015","unstructured":"Lascelles BDX, Knazovicky D, Case B, Freire M, Innes JF, Drew AC, et al. A canine-specific anti-nerve growth factor antibody alleviates pain and improves mobility and function in dogs with degenerative joint disease-associated pain. BMC Vet Res. 2015;11:101.","journal-title":"BMC Vet Res"},{"key":"3594_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1186\/s12917-018-1569-y","volume":"14","author":"T Olivry","year":"2018","unstructured":"Olivry T, Bensignor E, Favrot C, Griffin CE, Hill PB, Mueller RS, et al. Development of a core outcome set for therapeutic clinical trials enrolling dogs with atopic dermatitis (COSCAD\u201918). BMC Vet Res. 2018;14:238.","journal-title":"BMC Vet Res"},{"key":"3594_CR63","unstructured":"EMEA. Volume 9B of The Rules Governing Medicinal Products in the European Union \u2013 Guidelines on Pharmacovigilance for Medicinal Products for Veterinary Use. 2011. https:\/\/ec.europa.eu\/health\/system\/files\/2016-11\/vol_9b_2011-10_0.pdf. Accessed 22 Apr 2022."},{"key":"3594_CR64","doi-asserted-by":"publisher","DOI":"10.1002\/9781444322958","volume-title":"Veterinary Pharmacovigilance: Adverse Reactions to Veterinary Medicinal Products","author":"K Woodward","year":"2009","unstructured":"Woodward K. Veterinary Pharmacovigilance: Adverse Reactions to Veterinary Medicinal Products. 1st ed. Chichester: Blackwell Publishing Ltd.; 2009.","edition":"1"}],"container-title":["BMC Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03594-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12917-023-03594-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12917-023-03594-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,11]],"date-time":"2024-07-11T13:28:48Z","timestamp":1720704528000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcvetres.biomedcentral.com\/articles\/10.1186\/s12917-023-03594-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,7]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["3594"],"URL":"https:\/\/doi.org\/10.1186\/s12917-023-03594-4","relation":{},"ISSN":["1746-6148"],"issn-type":[{"value":"1746-6148","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,7]]},"assertion":[{"value":"3 August 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods used in the study were carried out in accordance with relevant EU guidelines and regulations.Ethical standards were assessed by the Bioethical Committee of the University of Perugia and the study was authorized with protocol number 2018\u201313. Written informed consent was obtained from the owners for the participation of their animals in this study, as well as for being included in the questionnaires.The study is reported in accordance with the ARRIVE guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"M.F.d.V. is a consultant for Innovet Italia. All the other authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"37"}}